Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 41
1947 36
1948 42
1949 20
1950 40
1951 56
1952 47
1953 41
1954 47
1955 53
1956 46
1957 37
1958 37
1959 21
1960 22
1961 21
1962 36
1963 101
1964 126
1965 101
1966 109
1967 117
1968 132
1969 111
1970 121
1971 133
1972 128
1973 131
1974 129
1975 111
1976 99
1977 91
1978 77
1979 100
1980 107
1981 97
1982 112
1983 97
1984 99
1985 110
1986 102
1987 96
1988 108
1989 121
1990 79
1991 80
1992 90
1993 104
1994 99
1995 94
1996 99
1997 91
1998 92
1999 90
2000 85
2001 75
2002 62
2003 72
2004 60
2005 81
2006 79
2007 65
2008 70
2009 92
2010 88
2011 96
2012 87
2013 107
2014 93
2015 99
2016 118
2017 103
2018 108
2019 108
2020 122
2021 118
2022 105
Text availability
Article attribute
Article type
Publication date

Search Results

6,430 results
Results by year
Filters applied: . Clear all
Page 1
The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis.
Hristovska AM, Duch P, Allingstrup M, Afshari A. Hristovska AM, et al. Anaesthesia. 2018 May;73(5):631-641. doi: 10.1111/anae.14160. Epub 2017 Dec 27. Anaesthesia. 2018. PMID: 29280475 Free article.
There were significantly fewer composite adverse events in the sugammadex group compared with neostigmine, with a risk ratio (95%CI) of 0.60 (0.49-0.74) (I(2) = 40%, 28 studies, n = 2298, number needed to treat (NNT): 8, GRADE: moderate quality). ...Sugammadex reverses neu …
There were significantly fewer composite adverse events in the sugammadex group compared with neostigmine, with a risk ratio (95%CI) …
Neostigmine Hyperinflation.
Hamel AG, Recker MW. Hamel AG, et al. J Pharm Pract. 2018 Aug;31(4):395-398. doi: 10.1177/0897190018762884. Epub 2018 Mar 11. J Pharm Pract. 2018. PMID: 29528806 No abstract available.
Intravenous neostigmine for postoperative acute colonic pseudo-obstruction.
Elsner JL, Smith JM, Ensor CR. Elsner JL, et al. Ann Pharmacother. 2012 Mar;46(3):430-5. doi: 10.1345/aph.1Q515. Epub 2012 Feb 28. Ann Pharmacother. 2012. PMID: 22388328 Review.
OBJECTIVE: To review the literature on the safety and effectiveness of neostigmine for the treatment of postoperative acute colonic pseudo-obstruction. ...One randomized controlled trial, 8 prospective and 3 retrospective observational studies, and 9 case reports evaluated …
OBJECTIVE: To review the literature on the safety and effectiveness of neostigmine for the treatment of postoperative acute colonic p …
Neostigmine for reversal of neuromuscular block in paediatric patients.
Yang L, Yang D, Li Q, Zuo Y, Lu D. Yang L, et al. Cochrane Database Syst Rev. 2014 May 5;(5):CD010110. doi: 10.1002/14651858.CD010110.pub2. Cochrane Database Syst Rev. 2014. PMID: 24793636 Review.
Therefore, whether neostigmine should be used routinely to reverse neuromuscular blockade in each paediatric patient is an important question for paediatric anaesthesiologists. ...AUTHORS' CONCLUSIONS: No RCTs were found that supported, or argued against, the routine use o …
Therefore, whether neostigmine should be used routinely to reverse neuromuscular blockade in each paediatric patient is an important …
Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis.
He W, Chen P, Lei Y, Xia L, Liu P, Zhu Y, Zeng H, Wu Y, Ke H, Huang X, Cai W, Sun X, Huang W, Sutton R, Zhu Y, Lu N. He W, et al. Crit Care. 2022 Mar 3;26(1):52. doi: 10.1186/s13054-022-03922-4. Crit Care. 2022. PMID: 35241135 Free PMC article. Clinical Trial.

Per-protocol analysis confirmed these results (P = 0.03). Stool volume was consistently higher in the neostigmine group during the 7-day observational period (all P < 0.05). Other secondary outcomes were not significantly different between neostigmine and convent

Per-protocol analysis confirmed these results (P = 0.03). Stool volume was consistently higher in the neostigmine group during the 7- …
Neostigmine-resistant curarization.
HUNTER AR. HUNTER AR. Br Med J. 1956 Oct 20;2(4998):919-21. doi: 10.1136/bmj.2.4998.919. Br Med J. 1956. PMID: 13364356 Free PMC article. No abstract available.
Neostigmine toxicity.
TETHER JE. TETHER JE. J Am Med Assoc. 1948 Jul 17;137(12):1078. doi: 10.1001/jama.1948.02890460074020. J Am Med Assoc. 1948. PMID: 18871862 No abstract available.
Atropine-neostigmine mixture.
Kopman AF. Kopman AF. Can J Anaesth. 1990 Mar;37(2):269-70. doi: 10.1007/BF03005489. Can J Anaesth. 1990. PMID: 2311160 No abstract available.
MYASTHENIA gravis.
[No authors listed] [No authors listed] Br Med J. 1956 Jun 2;1(4978):1283-4. Br Med J. 1956. PMID: 13316135 Free PMC article. No abstract available.
6,430 results